There is also a clear rationale to retrospectively analyse the interaction between HLA and treatment in other antigen-specific trials, especially where insulin has been used as the tolerising antigen given the association between insulin autoimmunity and HLA-DR4-DQ8. The gene discussed is INS; the disease is Autoimmunity.